SCHEMBL6880915

SCHEMBL6880915

NC(=O)c1ccccc1-c1cccc(N2CCOCC2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 3/20 0.52
JAK2 O60674 2/20 0.52
JAK1 P23458 2/20 0.52
TYK2 P29597 2/20 0.52
JAK3 P52333 2/20 0.52
KMO O15229 1/20 0.51
BCAT2 O15382 1/20 0.50
LMNA P02545 2/20 0.48
POLB P06746 1/20 0.48
HTT P42858 1/20 0.48
HSD17B10 Q99714 1/20 0.48
GPR55 Q9Y2T6 1/20 0.48
ATR Q13535 1/20 0.47
PARP1 P09874 1/20 0.46
AGXT P21549 1/20 0.46
BRD4 O60885 1/20 0.46
CREBBP Q92793 1/20 0.46
RPS6KA3 P51812 1/20 0.46
AURKA O14965 1/20 0.45
RPS6KB1 P23443 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1535781 0.88 BCAT2 (0.54) BCAT2POLBHTTHSD17B10PARP1
SCHEMBL2565236 0.86 BCAT2 (0.56) LRRK2JAK2JAK1TYK2JAK3
SCHEMBL27476310 0.84 GRM5 (0.50) JAK2JAK1TYK2JAK3BCAT2
SCHEMBL29789681 0.81 AOC3 (0.55) JAK2LMNAPOLBHTTHSD17B10
SCHEMBL22410905 0.78 JAK2 (0.48) JAK2JAK1TYK2JAK3KMO
SCHEMBL22410906 0.78 AKR1C3 (0.54) JAK2JAK1TYK2JAK3LMNA
SCHEMBL28090800 0.77 BCAT2 (0.64) BCAT2LMNAPOLBHTTRPS6KB1
SCHEMBL303084 0.77 KMO (0.77) LRRK2KMOLMNAHSD17B10PARP1
SCHEMBL29077217 0.77 LMNA (0.49) LRRK2KMOLMNAAGXTBRD4
SCHEMBL10908563 0.76 BCAT2 (0.77) BCAT2HSD17B10PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1243724-C Amide derivatives which are useful as cell factor inhibitors ASTRA ZENECA LTD (SE) 2006-03-01 CN disclosed
US-6821965-B1 IMPORTANT IN DISEASE OR MEDICAL CONDITIONS SUCH AS INFLAMMATION AND IMMUNOREGULATION ASTERZENECA AB (SE) 2004-11-23 US disclosed